The following represents disclosure information provided by faculty of the educational and scientific sessions. The Committee have reviewed all presented disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab versus ipilimumab for advanced melanoma: Final overall survival analysis of KEYNOTE-006.
 
Jacob Schachter
 
Employment - No Relationships to Disclose
 
Leadership - No Relationships to Disclose
 
Stock and Other Ownership Interests - No Relationships to Disclose
 
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Speakers' Bureau - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Research Funding - No Relationships to Disclose
 
Patents, Royalties, Other Intellectual Property - Merck Sharp & Dohme
 
Expert Testimony - No Relationships to Disclose
 
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Other Relationship - No Relationships to Disclose